Is­raeli API mak­er Wave­length buys up ma­jor­i­ty stake in In­di­an firm mak­ing drug start­ing ma­te­ri­als and in­ter­me­di­ates

As the Covid-19 pan­dem­ic con­tin­ues to chal­lenge the glob­al drug sup­ply chain, na­tions are look­ing for new ways to en­able na­tive pro­duc­ers to con­tin­ue scal­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.